Luyten GPM - Search Results

1

Anti-angiogenic therapy in uveal melanoma.

El Filali M, Van der Velden PA, Luyten GPM, Jager MJ. El Filali M, et al. Among authors: luyten gpm. Dev Ophthalmol. 2012;49:117-136. doi: 10.1159/000329591. Epub 2011 Oct 21. Dev Ophthalmol. 2012. PMID: 22042017 Review.

2

Cytokine-mediated modulation of integrin, ICAM-1 and CD44 expression on human uveal melanoma cells in vitro.

Creyghton WM, de Waard-Siebinga I, Danen EH, Luyten GP, van Muijen GN, Jager MJ. Creyghton WM, et al. Melanoma Res. 1995 Aug;5(4):235-42. doi: 10.1097/00008390-199508000-00005. Melanoma Res. 1995. PMID: 7496158

3

Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.

Ma D, Luyten GP, Luider TM, Jager MJ, Niederkorn JY. Ma D, et al. Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2293-301. Invest Ophthalmol Vis Sci. 1996. PMID: 8843913

4

Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.

Blom DJ, Mooy CM, Luyten GP, Kerkvliet S, Ouwerkerk I, Zwinderman AH, Schrier PI, Jager MJ. Blom DJ, et al. J Pathol. 1997 Jan;181(1):75-9. doi: 10.1002/(SICI)1096-9896(199701)181:1<75::AID-PATH724>3.0.CO;2-V. J Pathol. 1997. PMID: 9072006

5

Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines.

Blom DJ, De Waard-Siebinga I, Apte RS, Luyten GP, Niederkorn JY, Jager MJ. Blom DJ, et al. Melanoma Res. 1997 Apr;7(2):103-9. doi: 10.1097/00008390-199704000-00003. Melanoma Res. 1997. PMID: 9167175

6

Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.

Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ. Blom DJ, et al. Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1865-72. Invest Ophthalmol Vis Sci. 1997. PMID: 9286277

7

Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines.

van der Pol JP, Blom DJ, Flens MJ, Luyten GP, de Waard-Siebinga I, Koornneef L, Scheper RJ, Jager MJ. van der Pol JP, et al. Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2523-30. Invest Ophthalmol Vis Sci. 1997. PMID: 9375571

8

Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.

Blom DJ, Goslings WR, De Waard-Siebinga I, Luyten GP, Claas FH, Gorter A, Jager MJ. Blom DJ, et al. J Interferon Cytokine Res. 1997 Nov;17(11):695-700. doi: 10.1089/jir.1997.17.695. J Interferon Cytokine Res. 1997. PMID: 9402107

9

Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines.

Luyten GP, van der Spek CW, Brand I, Sintnicolaas K, de Waard-Siebinga I, Jager MJ, de Jong PT, Schrier PI, Luider TM. Luyten GP, et al. Melanoma Res. 1998 Feb;8(1):11-6. doi: 10.1097/00008390-199802000-00003. Melanoma Res. 1998. PMID: 9508371

10

Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.

Maat W, van der Slik AR, Verhoeven DH, Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T, Koning F, Jager MJ, van Bergen J. Maat W, et al. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2888-95. doi: 10.1167/iovs.08-2733. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters